• Ways to Give
  • Job Opportunities
  • Patient Portal
Decrease (-) Restore Default Increase (+)
Print    Email

Research Trials

ProMedica is dedicated to researching ways in which we can improve patient care. We are consistently running clinical trials that are open to new volunteers. The types and availability of trials can change monthly, weekly and sometimes even daily. To keep you up-to-date on these ever-changing opportunities, please check back frequently.

If you see a trial that interests you, please contact the appropriate person listed for that trial. This contact person is a clinical research coordinator. He or she can give you the status of a particular trial, as well as answer any of your questions. Please note, all of our studies have been approved by our ProMedica Institutional Review Board.

Current Research Trials

Unless otherwise noted, the links listed below allow you to download information about clinical trials in the form of a Microsoft Word (.doc) document.

Oncology (Cancer Care)

In partnership with ProMedica Cancer Institute, the ProMedica research team offers a variety of clinical research trials. On average, more than 150 cancer clinical trials for children and adults are active at any given time, including new therapeutic drugs, quality-of-life enhancement studies and more.

View enrolling adult oncology trials.
View enrolling pediatric oncology trials.

Cardiology (Heart Care)

Working collaboratively with ProMedica Heart and Vascular Institutes, cardiology researchers offer patients access to cutting-edge treatments. Trials vary and include the following goals and procedures: reducing risk factors; treating associated disease processes, such as hypertension (high blood pressure) or hypercholesterolemia (high cholesterol); and interventional procedures, including non-invasive, invasive and open-heart surgery.

View enrolling cardiology trials

Nephrology (Kidney Health)

Early detection and treatment can often keep chronic kidney disease from getting worse. When kidney disease progresses, it may eventually lead to kidney failure requiring dialysis, or a kidney transplant, to maintain life. Trials are aimed at finding new treatments for people with chronic kidney disease, both in early disease and during dialysis. Since many diseases, such as diabetes or high blood pressure, can affect the kidneys, many trials focus on the body as a whole in order to preserve kidney function.

View enrolling nephrology trials.

Orthopaedics (Bones, Joints, Ligaments, Tendons, Muscles, and Nerves)

In partnership with ProMedica Orthopaedic Institute, physicians and researchers implement studies in numerous orthopaedic treatment areas including bones, joints and sports medicine. Trials include both preventive medicine and treatment opportunities for patients.

View enrolling trials in orthopaedics.

ProMedica Toledo Children's Hospital Cystic Fibrosis Research Center

Funded through the National Cystic Fibrosis Foundation, the Center is one of several research sites throughout the country devoted to improving the health and longevity of people with cystic fibrosis through access to cutting-edge research trials.

View enrolling clinical trials dealing with cystic fibrosis.

Vascular (Blood Vessels)

The Jobst Vascular Institute participates in innovative medical and interventional clinical research studies to enhance the treatment of patients with vascular disease. Research specializing in the advanced treatment of peripheral arterial disease, carotid disease and abdominal aortic aneurysm has resulted in a number of research milestones.

Learn more about clinical research at Jobst Vascular Institute.

Maternal-Fetal Health

ProMedica provides Maternal-Fetal research studies in an effort to reduce adverse pregnancy outcomes and infant mortality, thus improving the heath care of mothers and their children. Research ranges from fertility studies to device studies in order to monitor the prenatal health of infants.

View enrolling maternal-fetal medicine trials.

See All Trials

Download an Excel document (.xls) of all enrolling clinical trials.